Insight on Respiratory in South and Central America

Published within

« | 1 | » »|

Type Product title / description Pub Price
Report
Report

Drug Discovery for Rare Diseases

Favorable legislation and recent commercial successes have stimulated growing interest in the discovery of novel orphan drugs. However, there are many strategic considerations that are peculiar to the R&D process for diseases of low prevalence.

Published By Datamonitor
31 Aug 2012 $2800
Buy
Report
Report

Stakeholder Insight: COPD in Emerging Markets (Brazil, India, China, US) - Key differences in treatment despite standardized guidelines

Datamonitor's survey of 300 respiratory experts in Brazil, India, China and the US addresses increased interest in COPD in the emerging markets. The US is included as a benchmark, providing unique insight and comparisons of COPD market dynamics.

Published By Datamonitor
22 Dec 2010 $15200
Buy

« | 1 | » »|

No help is available.